![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: von Haehling Stephan Anker Stefan D
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.14, Iss.2, 2005-02, pp. : 163-176
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Immunomodulation therapy in patients with chronic heart failure
Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adenosine therapy: a new approach to chronic heart failure
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. :